185 related articles for article (PubMed ID: 3304476)
1. Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.
Harvey J; de Klerk N; Berryman I; Sterrett G; Byrne M; Papadimitriou J
Breast Cancer Res Treat; 1987; 9(2):101-9. PubMed ID: 3304476
[TBL] [Abstract][Full Text] [Related]
2. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
3. The nuclear DNA content of human breast carcinoma. Associations with clinical stage, axillary lymph node status, estrogen receptor status and outcome.
Berryman IL; Harvey JM; Sterrett GF; Papadimitriou JM
Anal Quant Cytol Histol; 1987 Oct; 9(5):429-34. PubMed ID: 3675802
[TBL] [Abstract][Full Text] [Related]
4. The relationship of estrogen receptor status to DNA ploidy in breast cancer.
Tsuchiya A; Nihei M; Ando Y; Suzuki S; Kimijima I; Abe R
Surg Today; 1992; 22(2):105-9. PubMed ID: 1498488
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.
Ewers SB; Attewell R; Baldetorp B; Borg A; Fernö M; Långström E; Killander D
Breast Cancer Res Treat; 1992; 24(2):115-26. PubMed ID: 8443399
[TBL] [Abstract][Full Text] [Related]
6. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer.
Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
Int J Clin Oncol; 2001 Aug; 6(4):177-82. PubMed ID: 11706555
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.
von Rosen A; Rutqvist LE; Carstensen J; Fallenius A; Skoog L; Auer G
Breast Cancer Res Treat; 1989 Jan; 13(1):23-32. PubMed ID: 2706326
[TBL] [Abstract][Full Text] [Related]
9. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.
Yokoe T; Izuo M; Ishida T; Iino Y; Kawai T
Jpn J Surg; 1990 Sep; 20(5):491-7. PubMed ID: 2243441
[TBL] [Abstract][Full Text] [Related]
11. Nuclear DNA content in breast carcinoma with special reference to the parameters of malignant potentiality.
Suehiro S; Hamada Y; Toi M; Nakamura T; Niimoto M; Hattori T
Jpn J Surg; 1990 Jan; 20(1):115-8. PubMed ID: 2304282
[TBL] [Abstract][Full Text] [Related]
12. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Jonsson H
Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
[TBL] [Abstract][Full Text] [Related]
13. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
Keyhani-Rofagha S; O'Toole RV; Farrar WB; Sickle-Santanello B; DeCenzo J; Young D
Cancer; 1990 Apr; 65(7):1577-82. PubMed ID: 2311069
[TBL] [Abstract][Full Text] [Related]
14. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
Friedman NS; Freedman MD
Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases.
Fallenius AG; Franzén SA; Auer GU
Cancer; 1988 Aug; 62(3):521-30. PubMed ID: 3390793
[TBL] [Abstract][Full Text] [Related]
17. Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer.
Feichter GE; Mueller A; Kaufmann M; Haag D; Born IA; Abel U; Klinga K; Kubli F; Goerttler K
Int J Cancer; 1988 Jun; 41(6):823-8. PubMed ID: 3372059
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.
Fernö M; Baldetorp B; Borg A; Olsson H; Sigurdsson H; Killander D
Acta Oncol; 1992; 31(2):157-65. PubMed ID: 1622630
[TBL] [Abstract][Full Text] [Related]
19. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
[TBL] [Abstract][Full Text] [Related]
20. Tumour DNA ploidy as an independent prognostic factor in breast cancer.
Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Koivula T
Br J Cancer; 1987 Nov; 56(5):637-42. PubMed ID: 3426929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
